4//SEC Filing
Cerulean Pharma Inc. 4
Accession 0001209191-17-002978
$DARECIK 0001401914operating
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 5:13 PM ET
Size
8.0 KB
Accession
0001209191-17-002978
Insider Transaction Report
Form 4
GUIFFRE CHRISTOPHERD T
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2017-01-06+150,000→ 150,000 totalExercise: $0.82Exp: 2027-01-05→ Common Stock (150,000 underlying) - Award
Stock Option (right to buy)
2017-01-06+150,000→ 150,000 totalExercise: $0.82Exp: 2027-01-05→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]This option was granted on January 6, 2017. The shares underlying the option are scheduled to vest in equal monthly installments over four years from January 1, 2017.
- [F2]This option was granted on January 6, 2017. The option is scheduled to vest as to 25% of the shares on the six-month anniversary of January 1, 2017 and as to an additional 25% of the original number of shares at the end of each six-month period of continuous service thereafter until January 1, 2019.
Documents
Issuer
Cerulean Pharma Inc.
CIK 0001401914
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001401914
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 5:13 PM ET
- Size
- 8.0 KB